Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease. - Node K; Batterham RL; Liu-Seifert H; Li R; Yoshino M; Oura T; Tanizawa Y; Komuro I (Current medical research and opinion, 2026)